The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Impact of Vaccines; Health, Economic and Social Perspectives
Open accessAbstract
In the 20th century, the development, licensing and implementation of vaccines as part of large, systematic immunization programs started to address health inequities that existed globally. However, at the time of writing, access to vaccines that prevent life-threatening infectious diseases remains unequal to all infants, children and adults in the world. This is a problem that many individuals and agencies are working hard to address globally. As clinicians and biomedical scientists we often focus on the health benefits that vaccines provide, in the prevention of ill-health and death from infectious pathogens. Here we discuss the health, economic and social benefits of vaccines that have been identified and studied in recent years, impacting all regions and all age groups. After learning of the emergence of SARS-CoV-2 virus in December 2019, and its potential for global dissemination to cause COVID-19 disease was realized, there was an urgent need to develop vaccines at an unprecedented rate and scale. As we appreciate and quantify the health, economic and social benefits of vaccines and immunization programs to individuals and society, we should endeavor to communicate this to the public and policy makers, for the benefit of endemic, epidemic, and pandemic diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
A novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
Chan, J. F.-W., Yuan, S., Kok, K.-H., To, K. K.-W., Chu, H., Yang, J., Xing, F., Liu, J., Yip, C. C.-Y., Poon, R. W.-S., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30154-9 · Cited by 8,944
Liu, Y.-Y., Wang, Y., Walsh, T. R., Yi, L.-X., Zhang, R., Spencer, J., Doi, Y., Tian, G., Dong, B., Huang, X., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00424-7 · Cited by 5,398
Whitney, C. G., Farley, M. M., Hadler, J., Harrison, L. H., Bennett, N. M., Lynfield, R., Reingold, A., Cieslak, P. R., Pilishvili, T., Jackson, D., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022823 · Cited by 2,228
The COVID-19 vaccine development landscape
Thanh Le, T., Andreadakis, Z., Kumar, A., Gómez Román, R., Tollefsen, S., Saville, M., & Mayhew, S. (2020) · Nature Reviews Drug Discovery · doi:10.1038/d41573-020-00073-5 · Cited by 1,954
Logan, L. K., & Weinstein, R. A. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw282 · Cited by 1,584
Immunosenescence and Inflamm-Aging As Two Sides of the Same Coin: Friends or Foes?
Fulop, T., Larbi, A., Dupuis, G., Le Page, A., Frost, E. H., Cohen, A. A., Witkowski, J. M., & Franceschi, C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01960 · Cited by 1,364
Vaccination greatly reduces disease, disability, death and inequity worldwide
Andre, F., Booy, R., Bock, H., Clemens, J., Datta, S., John, T., Lee, B., Lolekha, S., Peltola, H., Ruff, T., et al. (2008) · Bulletin of the World Health Organization · doi:10.2471/blt.07.040089 · Cited by 1,234
Kirnbauer, R., Booy, F., Cheng, N., Lowy, D. R., & Schiller, J. T. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12180 · Cited by 1,110
Kyaw, M. H., Lynfield, R., Schaffner, W., Craig, A. S., Hadler, J., Reingold, A., Thomas, A. R., Harrison, L. H., Bennett, N. M., Farley, M. M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa051642 · Cited by 881
The Health and Wealth of Nations
Bloom, D. E., & Canning, D. (2000) · Science · doi:10.1126/science.287.5456.1207 · Cited by 848
Plotkin, S. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1400472111 · Cited by 642
Self-citationRoush, S. W. (2007) · JAMA · doi:10.1001/jama.298.18.2155 · Cited by 633
Schneerson, R., Barrera, O., Sutton, A., & Robbins, J. B. (1980) · The Journal of experimental medicine · doi:10.1084/jem.152.2.361 · Cited by 625
A role for Streptococcus pneumoniae in virus-associated pneumonia
Madhi, S. A., Klugman, K. P., & The Vaccine Trialist Group (2004) · Nature Medicine · doi:10.1038/nm1077 · Cited by 565
The 1918 Influenza Pandemic: Insights for the 21st Century
Morens, D. M., & Fauci, A. S. (2007) · The Journal of Infectious Diseases · doi:10.1086/511989 · Cited by 536
Moss, W. J. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31463-0 · Cited by 530
Maintaining protection against invasive bacteria with protein–polysaccharide conjugate vaccines
Pollard, A. J., Perrett, K. P., & Beverley, P. C. (2009) · Nature Reviews Immunology · doi:10.1038/nri2494 · Cited by 485
Measles virus infection diminishes preexisting antibodies that offer protection from other pathogens
Mina, M. J., Kula, T., Leng, Y., Li, M., de Vries, R. D., Knip, M., Siljander, H., Rewers, M., Choy, D. F., Wilson, M. S., et al. (2019) · Science · doi:10.1126/science.aay6485 · Cited by 466
Simply put: Vaccination saves lives
Orenstein, W. A., & Ahmed, R. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1704507114 · Cited by 446
THE USE OF YELLOW FEVER VIRUS MODIFIED BY IN VITRO CULTIVATION FOR HUMAN IMMUNIZATION
Theiler, M., & Smith, H. H. (1937) · Journal of Experimental Medicine · doi:10.1084/jem.65.6.787 · Cited by 445
Impact of Meningococcal Serogroup C Conjugate Vaccines on Carriage and Herd Immunity
Maiden, M. C. J., Ibarz-Pavón, A. B., Urwin, R., Gray, S. J., Andrews, N. J., Clarke, S. C., Walker, A. M., Evans, M. R., Kroll, J. S., Neal, K. R., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/527401 · Cited by 442
Long-term measles-induced immunomodulation increases overall childhood infectious disease mortality
Mina, M. J., Metcalf, C. J. E., de Swart, R. L., Osterhaus, A. D. M. E., & Grenfell, B. T. (2015) · Science · doi:10.1126/science.aaa3662 · Cited by 421
The global value of vaccination
Ehreth, J. (2003) · Vaccine · doi:10.1016/s0264-410x(02)00623-0 · Cited by 408
Serruto, D., Bottomley, M. J., Ram, S., Giuliani, M. M., & Rappuoli, R. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.01.033 · Cited by 404
Expanded Programme on Immunization
(2001) · Immunization · doi:10.1002/9780470693841.ch8 · Cited by 392
Return On Investment From Childhood Immunization In Low- And Middle-Income Countries, 2011–20
Ozawa, S., Clark, S., Portnoy, A., Grewal, S., Brenzel, L., & Walker, D. G. (2016) · Health Affairs · doi:10.1377/hlthaff.2015.1086 · Cited by 371
Cost-effectiveness of a routine varicella vaccination program for U.S. children
(1994) · The Journal of Pediatrics · doi:10.1016/s0022-3476(94)70148-2 · Cited by 306
Tabrizi, S. N., Brotherton, J. M. L., Kaldor, J. M., Skinner, S. R., Liu, B., Bateson, D., McNamee, K., Garefalakis, M., Phillips, S., Cummins, E., et al. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70841-2 · Cited by 301
Gouglas, D., Thanh Le, T., Henderson, K., Kaloudis, A., Danielsen, T., Hammersland, N. C., Robinson, J. M., Heaton, P. M., & Røttingen, J.-A. (2018) · The Lancet Global Health · doi:10.1016/s2214-109x(18)30346-2 · Cited by 280
Cost-effectiveness of a Routine Varicella Vaccination Program for US Children
Lieu, T. A. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03510290057037 · Cited by 270
Economic Evaluation of the Routine Childhood Immunization Program in the United States, 2009
Zhou, F., Shefer, A., Wenger, J., Messonnier, M., Wang, L. Y., Lopez, A., Moore, M., Murphy, T. V., Cortese, M., & Rodewald, L. (2014) · Pediatrics · doi:10.1542/peds.2013-0698 · Cited by 259
Simonsen, L., Taylor, R. J., Young-Xu, Y., Haber, M., May, L., & Klugman, K. P. (2011) · mBio · doi:10.1128/mbio.00309-10 · Cited by 256
Daugla, D., Gami, J., Gamougam, K., Naibei, N., Mbainadji, L., Narbé, M., Toralta, J., Kodbesse, B., Ngadoua, C., Coldiron, M., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61612-8 · Cited by 256
THE EFFECT OF PROLONGED CULTIVATION IN VITRO UPON THE PATHOGENICITY OF YELLOW FEVER VIRUS
Theiler, M., & Smith, H. H. (1937) · Journal of Experimental Medicine · doi:10.1084/jem.65.6.767 · Cited by 245
Heukelbach, J., Alencar, C. H., Kelvin, A. A., De Oliveira, W. K., & Pamplona de Góes Cavalcanti, L. (2016) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.8217 · Cited by 239
Bloom, D. E., Canning, D., & Weston, M. (2017) · Fighting the Diseases of Poverty · doi:10.4324/9780203791950-8 · Cited by 238
Palmer, T., Wallace, L., Pollock, K. G., Cuschieri, K., Robertson, C., Kavanagh, K., & Cruickshank, M. (2019) · BMJ · doi:10.1136/bmj.l1161 · Cited by 237
Expanded programme on immunization.
Keja, K., Chan, C., Hayden, G., & Henderson, R. H. (1988) · PubMed · Cited by 229
Curns, A. T., Steiner, C. A., Barrett, M., Hunter, K., Wilson, E., & Parashar, U. D. (2010) · The Journal of Infectious Diseases · doi:10.1086/652403 · Cited by 207
The global eradication of smallpox
Strassburg, M. A. (1982) · American Journal of Infection Control · doi:10.1016/0196-6553(82)90003-7 · Cited by 193
Bärnighausen, T., Bloom, D. E., Cafiero-Fonseca, E. T., & O’Brien, J. C. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1400475111 · Cited by 187
The Threat of Antimicrobial Resistance on the Human Microbiome
Brinkac, L., Voorhies, A., Gomez, A., & Nelson, K. E. (2017) · Microbial Ecology · doi:10.1007/s00248-017-0985-z · Cited by 186
The Effects of Child Mortality Changes on Fertility Choice and Parental Welfare
Sah, R. K. (1991) · Journal of Political Economy · doi:10.1086/261768 · Cited by 185
Maternal immunisation: collaborating with mother nature
Marchant, A., Sadarangani, M., Garand, M., Dauby, N., Verhasselt, V., Pereira, L., Bjornson, G., Jones, C. E., Halperin, S. A., Edwards, K. M., et al. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30229-3 · Cited by 183
Involvement of Human Papillomaviruses in Cervical Cancer
Wang, X., Huang, X., & Zhang, Y. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02896 · Cited by 173
Development and characterization of cold-adapted viruses for use as live virus vaccines
Maassab, H. F., & DeBorde, D. C. (1985) · Vaccine · doi:10.1016/0264-410x(85)90124-0 · Cited by 172
Rinderpest: the veterinary perspective on eradication
Roeder, P., Mariner, J., & Kock, R. (2013) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2012.0139 · Cited by 164
Additive preventive effect of influenza and pneumococcal vaccines in elderly persons
Christenson, B., Hedlund, J., Lundbergh, P., & Örtqvist, Å. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00063504 · Cited by 162
Petrova, V. N., Sawatsky, B., Han, A. X., Laksono, B. M., Walz, L., Parker, E., Pieper, K., Anderson, C. A., de Vries, R. D., Lanzavecchia, A., et al. (2019) · Science Immunology · doi:10.1126/sciimmunol.aay6125 · Cited by 157
Plans-Rubió, P. (2012) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.18444 · Cited by 155
The broader economic impact of vaccination: reviewing and appraising the strength of evidence
Jit, M., Hutubessy, R., Png, M. E., Sundaram, N., Audimulam, J., Salim, S., & Yoong, J. (2015) · BMC Medicine · doi:10.1186/s12916-015-0446-9 · Cited by 153
Deogaonkar, R., Hutubessy, R. C. W., van der Putten, I. M., Evers, S., & Jit, M. (2012) · BMC Public Health · doi:10.1186/1471-2458-12-878 · Cited by 148
Immunization of Humans with Polyribophosphate, the Capsular Antigen of Hemophilus influenzae, Type b
Anderson, P. W., Peter, G., Johnston, R. B., Wetterlow, L. H., & Smith, D. H. (1972) · Journal of Clinical Investigation · doi:10.1172/jci106794 · Cited by 138
Bärnighausen, T., Bloom, D. E., Canning, D., Friedman, A. S., Levine, O. S., O’Brien, J., Privor-Dumm, L. A., & Walker, D. G. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.11.090 · Cited by 129
Meningococcal infections. 2. Field trial of group C meningococcal polysaccharide vaccine in 1969-70.
Gold, R., & Artenstein, M. S. (1971) · Europe PMC (PubMed Central) · Cited by 121
Paulke‐Korinek, M., Kundi, M., Rendi‐Wagner, P., et al. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.01.104 · Cited by 121
The Efficacy of Influenza Vaccine for Healthy Children
Manzoli, L., Schioppa, F. S., Boccia, A., & Villari, P. (2007) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000253053.01151.bd · Cited by 120
Aaby, P., Bhuiya, A., Nahar, L., Knudsen, K. M., de Francisco, A., & Strong, M. (2003) · International Journal of Epidemiology · doi:10.1093/ije/dyg005 · Cited by 117
Vaccination Coverage Among Children Aged 19–35 Months — United States, 2016
Hill, H. A., Elam–Evans, L. D., Yankey, D., Singleton, J. A., & Kang, Y. (2017) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6643a3 · Cited by 115
The public health value of vaccines beyond efficacy: methods, measures and outcomes
Wilder‐Smith, A., Longini, I. M., ZUBER, P. L. F., Bärnighausen, T., Edmunds, W. J., Dean, N. E., Spicher, V. M., Benissa, M.-R., & Gessner, B. D. (2017) · BMC Medicine · doi:10.1186/s12916-017-0911-8 · Cited by 114
Development of Acellular Pertussis Vaccines
Sato, Y., & Sato, H. (1999) · Biologicals · doi:10.1006/biol.1999.0181 · Cited by 112
The effect of vaccination on children's physical and cognitive development in the Philippines
Bloom, D. E., Canning, D., & Shenoy, E. S. (2011) · Applied Economics · doi:10.1080/00036846.2011.566203 · Cited by 112
Verguet, S., Murphy, S. M., Anderson, B., Johansson, K. A., Glass, R. I., & Rheingans, R. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.07.014 · Cited by 109
Zika infection and the development of neurological defects
Russo, F. B., Jungmann, P., & Beltrão-Braga, P. C. B. (2017) · Cellular Microbiology · doi:10.1111/cmi.12744 · Cited by 100
Healthcare and disease burden among refugees in long-stay refugee camps at Lesbos, Greece
Hermans, M. P. J., Kooistra, J., Cannegieter, S. C., Rosendaal, F. R., Mook-Kanamori, D. O., & Nemeth, B. (2017) · European Journal of Epidemiology · doi:10.1007/s10654-017-0269-4 · Cited by 98
Diphtheria Toxoid as an Immunising Agent
Glenny, A. T., & Hopkins, B. E. (1923) · PubMed Central · Cited by 96
Geddes, A. M. (2006) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2005.11.009 · Cited by 94
PALMU, A. A. I., Jokinen, J., Nieminen, H. P., Rinta‐Kokko, H., Ruokokoski, E., Puumalainen, T., Borys, D., Lommel, P., Traskine, M., Moreira, M., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70338-4 · Cited by 92
Funk, S., Knapp, J. K., Lebo, E. J., Reef, S. E., Dabbagh, A. J., Kretsinger, K., Jit, M., Edmunds, W. J., & Strebel, P. M. (2019) · BMC Medicine · doi:10.1186/s12916-019-1413-7 · Cited by 91
Pneumococcal Polysaccharide Vaccines
AUSTRIAN, R. C. (1989) · Clinical Infectious Diseases · doi:10.1093/clinids/11.supplement_3.s598 · Cited by 87
Nunes, M. C., Cutland, C., Jones, S., Downs, S., Weinberg, A., Ortiz, J. R., Neuzil, K. M., Simões, E. A. F., Klugman, K. P., & Madhi, S. A. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix497 · Cited by 87
The New Pentavalent Rotavirus Vaccine Composed of Bovine (Strain WC3) -Human Rotavirus Reassortants
Clark, H. F., Offit, P. A., Plotkin, S. A., & Heaton, P. M. (2006) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000220283.58039.b6 · Cited by 83
Self-citationEradication versus control: the economics of global infectious disease policies.
Barrett, S. A. (2004) · Europe PMC (PubMed Central) · Cited by 83
Comparative impact assessment of child pneumonia interventions
Niessen, L. (2009) · Bulletin of the World Health Organization · doi:10.2471/blt.08.050872 · Cited by 81
Peltola, H., Aavitsland, P., Hansen, K. G., Jónsdóttir, K., Nøkleby, H., & Romanus, V. (1999) · The Journal of Infectious Diseases · doi:10.1086/314535 · Cited by 81
Estimating the full public health value of vaccination
Gessner, B. D., Kaslow, D. C., Louis, J. A., Neuzil, K. M., O’Brien, K. L., Picot, V., Pang, T., Parashar, U. D., Saadatian‐Elahi, M., & Nelson, C. B. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.09.048 · Cited by 80
Abadom, T. R., Smith, A. D., Tempia, S., Madhi, S. A., Cohen, C., & Cohen, A. L. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.09.011 · Cited by 71
Guillonneau, R., Baraquet, C., Bazire, A., & Molmeret, M. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01960 · Cited by 70
Strategies to improve maternal vaccination acceptance
Wilson, R., Paterson, P., & Larson, H. J. (2019) · BMC Public Health · doi:10.1186/s12889-019-6655-y · Cited by 66
Vaccines for epidemic infections and the role of CEPI
Plotkin, S. A. (2017) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2017.1306615 · Cited by 60
Self-citationGrizas, A. P., Camenga, D. R., & Vázquez, M. (2011) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e32834e8fe9 · Cited by 51
Measles vaccination improves the equity of health outcomes: evidence from Bangladesh
Bishai, D. M., Koenig, M., & Khan, M. A. (2002) · Health Economics · doi:10.1002/hec.732 · Cited by 50
Riumalló‐Herl, C., Chang, A. Y., Clark, S. E., Constenla, D. O., Clark, A. D., Brenzel, L., & Verguet, S. (2018) · BMJ Global Health · doi:10.1136/bmjgh-2017-000613 · Cited by 44
Effect of Maternal Influenza Vaccination on Hospitalization for Respiratory Infections in Newborns
Regan, A. K., de Klerk, N. H., Moore, H. C., Omer, S. B., SHELLAM, G. R., & Effler, P. V. (2016) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000001258 · Cited by 42
Vaccine-preventable diseases in lower-middle-income countries
Turner, H. C., Thwaites, G. E., & Clapham, H. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30478-x · Cited by 37
Vaccines, global health and social equity
Levine, M. M., & Robins-Browne, R. M. (2009) · Immunology and Cell Biology · doi:10.1038/icb.2009.15 · Cited by 36
EXTERNALITIES IN PROGRAM EVALUATION: THE IMPACT OF A WOMEN'S EMPOWERMENT PROGRAM ON IMMUNIZATION
Janssens, W. (2011) · Journal of the European Economic Association · doi:10.1111/j.1542-4774.2011.01041.x · Cited by 35
The intangible benefits of vaccination – what is the true economic value of vaccination?
Bonanni, P., Picazo, J. J., & Rémy, V. (2015) · Journal of Market Access & Health Policy · doi:10.3402/jmahp.v3.26964 · Cited by 33
Global poliomyelitis eradication: status and implications
Fine, P., & Griffiths, U. K. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60533-9 · Cited by 28
Hajjeh, R. A. (2011) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2011.0046 · Cited by 28
Soergel, P., Makowski, L., Schippert, C., STABOULIDOU, I., Hille, U., & Hillemanns, P. (2012) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.18519 · Cited by 26
The societal value of vaccination in developing countries
Shearley, A. (1999) · Vaccine · doi:10.1016/s0264-410x(99)00303-5 · Cited by 24
Domínguez, F., Castilla, J., Godoy, P., Delgado‐Rodríguez, M., Sáez, M., Soldevila, N., Astray, J., Mayoral, J. M., Martín, V., Quintana, J. M., et al. (2013) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e318280a34b · Cited by 18
Sur la vaccination charbonneuse
Mathieu, E. (1882) · Recueil de Médecine Vétérinaire · doi:10.3406/rmv.1882.2933 · Cited by 18
Hinman, A. R., & McKinlay, M. A. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.09.033 · Cited by 17
The Problems with Polio: Toward Eradication
Lien, G., & Heymann, D. L. (2013) · Infectious Diseases and Therapy · doi:10.1007/s40121-013-0014-6 · Cited by 15
The Expanded Programme on Immunization: the 1974 Resolution by the World Health Assembly.
(1985) · PubMed · Cited by 14
Chen, M., Rodrigues, C. M. C., Harrison, O. B., Zhang, C., Tan, T., Chen, J., Zhang, X., Chen, M., & Maiden, M. C. J. (2018) · Scientific Reports · doi:10.1038/s41598-018-30048-x · Cited by 10
Self-citationEpidemiology and Natural History of Chronic Hepatitis B Virus Infection
Bogler, Y., Wong, R. J., & Gish, R. G. (2017) · Springer eBooks · doi:10.1007/978-981-10-4843-2_4 · Cited by 7
Cited by
Acceptance and attitudes toward COVID-19 vaccines: A cross-sectional study from Jordan
El-Elimat, T., AbuAlSamen, M. M., Almomani, B. A., Al-Sawalha, N. A., & Alali, F. Q. (2021) · PLOS ONE · doi:10.1371/journal.pone.0250555 · Cited by 551
Deiana, G., Dettori, M., Arghittu, A., Azara, A., Gabutti, G., & Castiglia, P. (2023) · Vaccines · doi:10.3390/vaccines11071217 · Cited by 168
Vaccination against β-Amyloid as a Strategy for the Prevention of Alzheimer’s Disease
Mantile, F., & Prisco, A. (2020) · Biology · doi:10.3390/biology9120425 · Cited by 56
The power of phages: revolutionizing cancer treatment
Islam, M. S., Fan, J., & Pan, F. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1290296 · Cited by 50
A citywide experiment testing the impact of geographically targeted, high-pay-off vaccine lotteries
Milkman, K. L., Gandhi, L., Ellis, S. F., Graci, H. N., Gromet, D. M., Mobarak, R. S., Buttenheim, A. M., Duckworth, A. L., Pope, D., Stanford, A., et al. (2022) · Nature Human Behaviour · doi:10.1038/s41562-022-01437-0 · Cited by 44
Metadata
- Authors
- Rodrigues, C. M. C., & Plotkin, S. A.
- Venue
- Frontiers in Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2020-07-14
- Volume
- 11
- Pages
- 1526-1526
- ISSN
- 1664-302X (ISSN-L)
- OpenAlex
- W3043483772
- Cited by
- 737
- References
- 101
- FWCI
- 44.86
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.